Trial intelligence / Profile preview

Effect of Patient Education on Adherence and Satisfaction in Epiduo Gel-Treated Acne Patients

2014-002509-39Phase 4Completed

Sponsor
Galderma
Start
Sep 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of adapalene + benzoyl peroxide in acne vulgaris (2 arms), sponsored by Galderma. Primary endpoint: Treatment adherence. Started Sep 2014; status: completed.

02

Drugs

adapalene + benzoyl peroxide
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on 2014-002509-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002509-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call